VITA LIFE SCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.2 AUD | -1.79% |
|
-5.58% | +23.60% |
| Sales 2022 | 66.89M 43.87M 59.88M | Sales 2023 | 74.16M 48.64M 66.4M | Capitalization | 95.85M 62.86M 85.82M |
|---|---|---|---|---|---|
| Net income 2022 | 7M 4.59M 6.27M | Net income 2023 | 9M 5.9M 8.06M | EV / Sales 2022 | 0.92 x |
| Net cash position 2022 | 15.09M 9.89M 13.51M | Net cash position 2023 | 24.24M 15.9M 21.71M | EV / Sales 2023 | 0.97 x |
| P/E ratio 2022 |
10.3
x | P/E ratio 2023 |
10.7
x | Employees | - |
| Yield 2022 |
4.43% | Yield 2023 |
5.06% | Free-Float | 24.01% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.79% | ||
| 1 week | -5.58% | ||
| Current month | -9.09% | ||
| 1 month | -9.84% | ||
| 3 months | +16.40% | ||
| 6 months | +22.22% | ||
| Current year | +23.60% |
1 week
2.15
2.34
1 month
2.152.47
Current year
1.732.50
1 year
1.422.50
3 years
0.982.60
5 years
0.542.60
10 years
0.542.60
| Managers | Title | Age | Since |
|---|---|---|---|
Andrew OKeefe
CEO | Chief Executive Officer | - | 16-12-31 |
Chin Leng Khoo
DFI | Director of Finance/CFO | - | 03-12-31 |
June Lau
COO | Chief Operating Officer | - | 03-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Henry Townsing
CHM | Chairman | 68 | 11-12-21 |
Andrew OKeefe
CEO | Chief Executive Officer | - | 16-12-31 |
Peter Osborne
BRD | Director/Board Member | - | 23-07-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-28 | 2.2 | -1.79% | 40 |
| 24-04-26 | 2.24 | +4.19% | 587 |
| 24-04-24 | 2.15 | -2.27% | 1,649 |
| 24-04-23 | 2.2 | -5.58% | 22,176 |
| 24-04-22 | 2.33 | -0.85% | 105 |
Delayed Quote Australian S.E., April 28, 2024 at 10:31 pm
More quotes
Vita Life Sciences Limited (Vita Life) is a pharmaceutical and healthcare company. The Company is involved in formulating, packaging, sales and distributing vitamins and supplements. Its core business is the development and distribution of over-the-counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. Its brand portfolio includes Herbs of Gold, VitaHealth, VitaScience and VitaLife. Herbs of Gold brand produces premium herbal, mineral, vitamin and superfood products. VitaHealth brand offers a comprehensive range of nutritional products that cater to every health need, from inner wellness to outer radiance. VitaScience is a vivacious nutritional supplement brand that offers practitioner strength quality formulations. Its subsidiaries include Vita Healthcare Asia Pacific Sdn Bhd, Herbs of Gold Sdn Bhd and others.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +23.60% | 81.43M | |
| +25.32% | 661B | |
| +26.74% | 566B | |
| -6.57% | 352B | |
| +20.26% | 332B | |
| +2.79% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -5.14% | 145B |
- Stock Market
- Equities
- VLS Stock
